Aridis Pharmaceuticals Inc

NASDAQ:ARDS   3:01:49 PM EDT
1.01
0.00 (0.00%)
Earnings Announcements

Aridis Pharmaceuticals Announces 2021 Fourth Quarter And Year-End Financial Results And Business Update

Published: 03/31/2022 22:11 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces 2021 Fourth Quarter and Year-end Financial Results and Business Update.
Qtrly Loss per Share $0.92.
Q4 Earnings per Share View $-0.41 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.46 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $1.58 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.